COLTRINI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.299
EU - Europa 2.569
AS - Asia 788
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 2
Totale 6.678
Nazione #
US - Stati Uniti d'America 3.289
PL - Polonia 1.085
CN - Cina 465
UA - Ucraina 382
DE - Germania 368
IT - Italia 222
GB - Regno Unito 153
HK - Hong Kong 118
FI - Finlandia 110
SG - Singapore 73
IE - Irlanda 65
VN - Vietnam 53
RU - Federazione Russa 47
IN - India 42
ES - Italia 31
FR - Francia 29
CZ - Repubblica Ceca 23
SE - Svezia 16
BE - Belgio 12
CA - Canada 10
NL - Olanda 9
IR - Iran 7
AU - Australia 6
EU - Europa 6
CH - Svizzera 5
PH - Filippine 5
TR - Turchia 5
KR - Corea 4
JP - Giappone 3
LK - Sri Lanka 3
PE - Perù 3
BD - Bangladesh 2
CL - Cile 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
NO - Norvegia 1
PK - Pakistan 1
TW - Taiwan 1
Totale 6.678
Città #
Warsaw 1.084
Fairfield 461
Woodbridge 348
Jacksonville 283
Ashburn 265
Ann Arbor 253
Houston 228
Cambridge 196
Chandler 173
Seattle 155
Wilmington 148
Brescia 142
Princeton 122
Hong Kong 114
Nanjing 97
Beijing 93
Dearborn 88
Dublin 65
Helsinki 59
New York 59
Dong Ket 52
Lancaster 42
Singapore 42
Nanchang 34
Des Moines 31
Los Angeles 28
Madrid 28
Jinan 25
Shenyang 23
Brno 22
Hebei 22
Shanghai 22
San Francisco 19
Tianjin 19
Washington 19
London 18
Milan 18
San Diego 18
Jiaxing 16
Changsha 15
Boardman 14
Brussels 12
San Mateo 12
Kunming 11
Falls Church 10
Haikou 9
Hangzhou 9
Nürnberg 9
Zhengzhou 9
Leawood 8
Taizhou 8
Verona 8
Ningbo 7
Ardabil 6
Augusta 6
Dronten 6
Hefei 6
Kilburn 6
Lanzhou 6
Munich 6
Norwalk 6
Phoenix 6
Turin 6
Chicago 5
Monmouth Junction 5
Toronto 5
Chiswick 4
Modena 4
Ottawa 4
Baliuag 3
Colombo 3
Guangzhou 3
Kocaeli 3
Lima 3
New Delhi 3
Orange 3
Santa Clara 3
Tokyo 3
Yellow Springs 3
Zurich 3
Amsterdam 2
Auburn Hills 2
Barcelona 2
Bratislava 2
Camerino 2
Canberra 2
Catania 2
Cerreto Guidi 2
Charlottesville 2
Fort Lauderdale 2
Fuzhou 2
Gunzenhausen 2
Highland Park 2
Indiana 2
Ivry-sur-seine 2
Lausanne 2
Naples 2
Nashville 2
Redwood City 2
Sejong 2
Totale 5.232
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 266
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 229
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 228
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 226
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 226
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 219
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 214
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 205
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 189
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 160
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 151
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 147
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 146
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 138
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 137
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 129
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 126
P2y1 and P2y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells. 125
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 125
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 124
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 122
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 121
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 114
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 112
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 111
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 110
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 109
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 109
Beta-Galactosylceramidase deficiency: neurovascular implications 108
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 103
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 102
Biochemical bases of the interaction of the human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies 100
Cardiac microvascular endothelial cells express a functional Ca2+ -sensing receptor 93
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 93
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. 86
The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells. 83
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 83
Role of inflammation in FGF2-driven angiogenesis 83
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 83
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 80
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 79
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 69
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. 68
Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. 67
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 67
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. 62
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 62
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 57
upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumor cell lines derived from BK virus/tat-transgenic mice 55
Different effects of mucosal, beef lung, and chemically modified heparin on selected biological properties of basic fibroblast growth factor 55
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 55
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 53
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 52
Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors 50
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 50
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. 49
The interaction of basic fibroblast growth factor (bFGF) with heparan sulfate proteoglycans: biochemical bases and biological implications 49
Impact of fibroblast growth factor-2 (FGF2) on tumor growth and vascularization: Establishing a "FGF2-dependent" tumor model 48
Interaction of HIV-1 tat protein with heparin:role of the backbone structure, sulfation, and size 46
Natural killer cell impairment in ovarian clear cell carcinoma 45
An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation 43
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 39
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 34
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 30
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 17
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 11
Totale 6.827
Categoria #
all - tutte 28.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.597 0 0 95 185 118 224 220 202 143 203 108 99
2020/20211.204 41 125 57 147 71 121 37 132 150 100 140 83
2021/2022626 41 115 10 16 11 45 43 31 25 80 60 149
2022/2023534 98 18 30 34 48 117 7 47 49 4 50 32
2023/2024670 46 42 79 24 29 92 33 26 126 47 16 110
2024/202528 9 14 5 0 0 0 0 0 0 0 0 0
Totale 6.827